| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 20 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRCL |
Stericycle Inc |
Director |
– • – |
2009-03-16 |
4 |
S |
$48.08 |
$2,594,931 |
D/D |
(53,971) |
2,635,618 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2009-03-17 |
4 |
S |
$48.40 |
$4,839,670 |
D/D |
(100,000) |
2,535,618 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-04-06 |
4 |
S |
$3.40 |
$288,575 |
D/D |
(85,000) |
3,633,779 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-06-01 |
4 |
S |
$58.95 |
$9,431,584 |
D/D |
(160,000) |
2,375,618 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-06-02 |
4 |
S |
$59.08 |
$9,453,424 |
D/D |
(160,000) |
2,215,618 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-06-03 |
4 |
S |
$59.92 |
$1,667,280 |
D/D |
(27,825) |
2,187,793 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-11-29 |
4 |
S |
$2.76 |
$4,683,500 |
D/D |
(1,700,000) |
6,087,521 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-07 |
4 |
S |
$77.78 |
$1,413,451 |
D/D |
(18,172) |
1,875,193 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-13 |
4 |
S |
$79.29 |
$3,171,552 |
D/D |
(40,000) |
1,835,193 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-12-14 |
4 |
S |
$2.58 |
$55,470 |
I/I |
(21,500) |
21,500 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2011-05-06 |
4 |
S |
$90.46 |
$4,975,163 |
D/D |
(55,000) |
1,757,246 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2011-05-09 |
4 |
S |
$90.87 |
$4,543,640 |
D/D |
(50,000) |
1,707,246 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2011-05-10 |
4 |
S |
$91.70 |
$4,407,502 |
D/D |
(48,064) |
1,659,182 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-09-11 |
4 |
S |
$92.98 |
$4,649,000 |
D/D |
(50,000) |
1,540,358 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-09-12 |
4 |
S |
$93.32 |
$4,666,000 |
D/D |
(50,000) |
1,490,358 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-12 |
4 |
S |
$94.26 |
$7,787,384 |
D/D |
(82,616) |
1,407,742 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-13 |
4 |
S |
$93.38 |
$8,016,953 |
D/D |
(85,853) |
1,321,889 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-14 |
4 |
S |
$93.31 |
$2,796,781 |
D/D |
(29,973) |
1,291,916 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-03-25 |
4 |
S |
$103.94 |
$99,259 |
I/I |
(955) |
393,455 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-03-25 |
4 |
S |
$103.92 |
$96,126 |
D/D |
(925) |
860,216 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-06-13 |
4 |
S |
$105.75 |
$200,073 |
I/I |
(1,892) |
27,110 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-12-20 |
4 |
S |
$96.40 |
$621,973 |
I/I |
(6,452) |
147,967 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-19 |
4 |
S |
$1.91 |
$836,809 |
D/D |
(438,120) |
6,919,392 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-20 |
4 |
S |
$1.90 |
$219,435 |
D/D |
(115,492) |
6,803,900 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-21 |
4 |
S |
$1.79 |
$1,143,164 |
D/D |
(638,639) |
6,165,261 |
0 |
- |
|
634 Records found
|
|
Page 20 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
